Text Size

PRINTO (the Paediatric Rheumatology International Trials Organisation)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Institute of Child Health.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Institute of Child Health
ClinicalTrials.gov Identifier:
NCT00415935
First received: December 22, 2006
Last updated: December 23, 2006
Last verified: December 2006
History of Changes
  Purpose

A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months


Condition Intervention
Juvenile Idiopathic Arthritis
 Drug: methotrexate

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Institute of Child Health:

Estimated Study Completion Date: December 2006
  Eligibility

Ages Eligible for Study:   up to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Any child with JIA who has gone into remission using methotrexate
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00415935

Contacts
Contact: Lucy Wedderburn, Dr l.wedderburn@ich.ucl.ac.uk

Locations
United Kingdom
Rheumatology ICH Recruiting
London, United Kingdom, WC1N 1EH
Contact: Lucy Wedderburn, Dr         l.wedderburn@ich.ucl.ac.uk    
Sponsors and Collaborators
Institute of Child Health
Investigators
Principal Investigator: Lucy Wedderburn, Dr Institute Of Child Health and Great Ormond Street Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00415935     History of Changes
Other Study ID Numbers: 04RU01
Study First Received: December 22, 2006
Last Updated: December 23, 2006
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Arthritis
Arthritis, Juvenile Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Arthritis, Rheumatoid
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases
Methotrexate
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
 Pharmacologic Actions
Therapeutic Uses
Antimetabolites, Antineoplastic
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Immunosuppressive Agents
Immunologic Factors
Antirheumatic Agents
Nucleic Acid Synthesis Inhibitors

ClinicalTrials.gov processed this record on May 23, 2013